Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F98Q6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,200
Award facts
- Contract value 100% obligated
- $10,199.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,199.50 to AmerisourceBergen Drug Corp for the supply of Taltz 80 mg/ml autoinjector on February 4, 2026. This firm fixed-price contract, which is not set-aside and was competitively awarded, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Taltz (ixekizumab) is a biologic medication used to treat various autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, regularly fulfills federal medical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its role as a critical vendor for military and veteran healthcare systems, positions it as a key supplier within the Defense Logistics Agency's Medical Supply Chain operations.
Quick answers
Who was awarded contract SPE2DR26F98Q6?
SPE2DR26F98Q6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F98Q6 worth?
The government has obligated $10,200 on SPE2DR26F98Q6.
Is contract SPE2DR26F98Q6 an order under another contract?
Yes. SPE2DR26F98Q6 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F98Q6 competed?
The extent of competition for SPE2DR26F98Q6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award